Showing 20 of 223 recruiting trials for “acute-promyelocytic-leukemia”
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
👨⚕️ Ryan D. Cassaday, MD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Apr 2026View details ↗
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
A Single-arm, Prospective Study of a Cladribine-Bridged LABU Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory MDS/AML in Elderly Patients
👨⚕️ Depei Wu, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Apr 2026View details ↗
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
👨⚕️ Justin E Tanner, PhD, St. Jude Children's Research Hospital📍 1 site📅 Started Mar 2026View details ↗
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
RecruitingNCT07422337 ↗
A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
👨⚕️ Lauren Appell, MD, Arkansas Children's Research Institute📍 2 sites📅 Started Jan 2026View details ↗
Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis
Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)
👨⚕️ Kanhatai Chiengthong, MD, King Chulalongkorn Memorial Hospital📍 3 sites📅 Started Jan 2026View details ↗
Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
👨⚕️ Kevin Curran, MD, Memorial Sloan Kettering Cancer Center📍 3 sites📅 Started Oct 2025View details ↗
Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.
👨⚕️ Bahaa W Bou Dargham, MD, Beirut Arab University and Hammoud Hospital University Medical Center📍 1 site📅 Started Oct 2025View details ↗
A Study of CTD402 in T-ALL/LBL Patients
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Page 1 of 12Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →